US: 800.298.5699
Int'l: +1.240.747.3093
 
Matching geography
Reports matching your search in:
 
 
Join Alert Me now!
Receive bi-weekly email alerts on new market research

Sign up today!
 

Pharmaceuticals Company Reports Market Research Reports & Industry Analysis

RSS Feeds

Pharmaceuticals Company Reports Industry Research & Market Reports

1  2  3    5    7  8  9  10  
Company Snapshot – Ajanta Pharma Limited
4/1/2015 | published by: Gyan Research and Analytics Pvt. Ltd.
Company Snapshot – Ajanta Pharma Limited  |  read more...
USD 99
Company Snapshot – AstraZeneca Pharma India Limited
4/1/2015 | published by: Gyan Research and Analytics Pvt. Ltd.
Company Snapshot – AstraZeneca Pharma India Limited  |  read more...
USD 99
Company Snapshot – Aarti Drugs Limited
4/1/2015 | published by: Gyan Research and Analytics Pvt. Ltd.
Company Snapshot – Aarti Drugs Limited  |  read more...
USD 99
Company Snapshot - Aurobindo Pharmaceuticals Limited
4/1/2015 | published by: Gyan Research and Analytics Pvt. Ltd.
Company Snapshot - Aurobindo Pharmaceuticals Limited  |  read more...
USD 99
Chemotherapy Induced Myelosuppression - Pipeline Review, H1 2015
3/19/2015 | published by: Global Markets Direct
... information on the therapeutic development for Chemotherapy Induced Myelosuppression, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest ...  |  read more...
USD 2,000
AbbVie Inc. (ABBV) - Financial and Strategic SWOT Analysis Review
3/23/2015 | published by: GlobalData
... a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your ...  |  read more...
USD 300
ALK-Abello AS (ALK B) - Financial and Strategic SWOT Analysis Review
3/17/2015 | published by: GlobalData
... you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand ...  |  read more...
USD 125
AngioGenex, Inc. - Product Pipeline Analysis, 2015 Update
3/18/2015 | published by: GlobalData
... drug that targets the action of the inhibitor of differentiation proteins. AngioGenex's product under preclinical development, AGX1053 is an antisense-type fusion molecule that prevents angiogenesis by inhibiting Id gene expression. The company's AGX51 molecule inhibits ...  |  read more...
USD 750
e-Therapeutics plc (ETX) - Financial and Strategic SWOT Analysis Review
3/17/2015 | published by: GlobalData
... a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your ...  |  read more...
USD 125
Evotec AG (EVT) - Financial and Strategic SWOT Analysis Review
3/17/2015 | published by: GlobalData
... a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your ...  |  read more...
USD 125
Kyowa Hakko Kirin Co., Ltd. (4151) - Financial and Strategic SWOT Analysis Review
3/23/2015 | published by: GlobalData
... bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you ...  |  read more...
USD 125
Ligand Pharmaceuticals, Inc. (LGND) - Financial and Strategic SWOT Analysis Review
3/17/2015 | published by: GlobalData
... you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand ...  |  read more...
USD 125
Mabion SA (MAB) - Financial and Strategic SWOT Analysis Review
3/23/2015 | published by: GlobalData
... a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your ...  |  read more...
USD 125
Navamedic ASA (NAVA) - Financial and Strategic SWOT Analysis Review
3/17/2015 | published by: GlobalData
... a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your ...  |  read more...
USD 125
Pfizer Inc. (PFE) - Financial and Strategic SWOT Analysis Review
3/23/2015 | published by: GlobalData
... a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your ...  |  read more...
USD 125
Clinical Research (UK) - Industry Report
4/1/2015 | published by: Plimsoll Publishing Ltd.
... graphical analysis – analysing the 110 largest Clinical Research (UK) companies. The Clinical Research (UK) report contains the most-up-to-date financial data and Plimsoll applies these figures to create their unique and authoritative analysis. Indeed, the ...  |  read more...
USD 560
Medical Logistics (UK) - Industry Report
4/1/2015 | published by: Plimsoll Publishing Ltd.
... graphical analysis – analysing the 40 largest Medical Logistics (UK) companies. The Medical Logistics (UK) report contains the most-up-to-date financial data and Plimsoll applies these figures to create their unique and authoritative analysis. Indeed, the ...  |  read more...
USD 560
Generic Pharmaceuticals (Global) - Industry Report
4/1/2015 | published by: Plimsoll Publishing Ltd.
... – analysing the 260 largest Generic Pharmaceuticals (Global) companies. The Generic Pharmaceuticals (Global) report contains the most-up-to-date financial data and Plimsoll applies these figures to create their unique and authoritative analysis. Indeed, the first section ...  |  read more...
USD 1,520
Pharmaceuticals Manufacturers (Global) - Industry Report
4/1/2015 | published by: Plimsoll Publishing Ltd.
... – analysing the 500 largest Pharmaceuticals Manufacturers (Global) companies. The Pharmaceuticals Manufacturers (Global) report contains the most-up-to-date financial data and Plimsoll applies these figures to create their unique and authoritative analysis. Indeed, the first section ...  |  read more...
USD 1,520
The Medicines Company (MDCO) - Financial and Strategic SWOT Analysis Review
3/17/2015 | published by: GlobalData
... you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand ...  |  read more...
USD 125
Javni Zavod Lekarna Ljubljana in Consumer Health (Slovenia)
3/24/2015 | published by: Euromonitor International
... of Rx and OTC healthcare products, as well as products for personal care and wellbeing. The company mainly focuses on improving cost efficiency and developing its private label products. Euromonitor International Local Company Profiles are ...  |  read more...
USD 150
Midsona Norge AS in Consumer Health (Norway)
3/23/2015 | published by: Euromonitor International
... interested in establishing itself as a major player in consumer health in Norway. This was further proved when Midsona launched a new cod liver oil brand to compete with the Nordic giant Orkla Health. Following ...  |  read more...
USD 150
Orkla Health AS in Consumer Health (Norway)
3/23/2015 | published by: Euromonitor International
... 17% share in the leading sports nutrition company Proteinfabrikken AS, the player is expected to increase both its online presence and enter sports nutrition. Orkla Health was granted the option to acquire the remaining shares ...  |  read more...
USD 150
Takeda Nycomed AS in Consumer Health (Norway)
3/23/2015 | published by: Euromonitor International
... position in chemists/pharmacies. Euromonitor International Local Company Profiles are a concise set of briefings detailing the strategic direction taken by a company. Discover key contact details, the company background and their competitive positioning through this ...  |  read more...
USD 150
Dexxon Ltd in Consumer Health (Israel)
3/27/2015 | published by: Euromonitor International
... with which to cooperate in order to create new products. In 2013, the company used its resources to buy shares in different companies all over the world and in doing so infiltrate new markets. The ...  |  read more...
USD 150
1  2  3    5    7  8  9  10